Matthew J. Memoli, a flu researcher who became acting director of NIAID under the Trump administration, has experienced a rapid ascension, which recently resulted in a funding award of up to $500 million for his vaccine research. Although this initiative aims to develop universal vaccines to protect against various viruses, experts question the wisdom of this direction, particularly given the ongoing cuts to HHS staff and defunding of numerous infectious disease-related projects, raising concerns about the overall national health strategy.
"The Trump administration elevated Matthew J. Memoli, a flu researcher with a small lab, to acting director of NIAID, overseeing significant cuts and firings, now he secures $500 million."
"Despite the promising nature of universal vaccines, concerns arise as the HHS continues to cut staff and divert funds from other vital infectious disease projects."
Collection
[
|
...
]